Gene · 54567
Papers4,267
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,267
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Methylation analysis by targeted bisulfite sequencing in large for gestational age (LGA) newborns: the LARGAN cohort. | Clin Epigenetics | 2023 | 38093359 | PubTator, text mining | PubMed |
| Jagged1 intracellular domain/SMAD3 complex transcriptionally regulates TWIST1 to drive glioma invasion. | Cell Death Dis | 2023 | 38092725 | PubTator, text mining | PubMed |
| Cancer stem cell-immune cell crosstalk in breast tumor microenvironment: a determinant of therapeutic facet. | Front Immunol | 2023 | 38090567 | PubTator, text mining | PubMed |
| LncRNA-HANR exacerbates malignant behaviors of cholangiocarcinoma cells through activating Notch pathway. | Heliyon | 2023 | 38076116 | PubTator, text mining | PubMed |
| Cracking the Endothelial Calcium (Ca2+) Code: A Matter of Timing and Spacing. | Int J Mol Sci | 2023 | 38069089 | PubTator, text mining | PubMed |
| Pathomechanisms of Diabetic Kidney Disease. | J Clin Med | 2023 | 38068400 | PubTator, text mining | PubMed |
| A pan-cancer analysis of TNFAIP8L1 in human tumors. | Medicine (Baltimore) | 2023 | 38065896 | PubTator, text mining | PubMed |
| Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial. | Sci Rep | 2023 | 38049525 | PubTator, text mining | PubMed |
| Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy. | MedComm (2020) | 2023 | 38045829 | PubTator, text mining | PubMed |
| Integrated analysis of microRNA and mRNA expression profiles in Preeclampsia. | BMC Med Genomics | 2023 | 38041082 | PubTator, text mining | PubMed |
| Mechanisms and Optimization Strategies of Paracrine Exosomes from Mesenchymal Stem Cells in Ischemic Heart Disease. | Stem Cells Int | 2023 | 38034060 | PubTator, text mining | PubMed |
| Integrating spatial and single-cell transcriptomics data using deep generative models with SpatialScope. | Nat Commun | 2023 | 38030617 | PubTator, text mining | PubMed |
| The Notch signaling-regulated angiogenesis in rheumatoid arthritis: pathogenic mechanisms and therapeutic potentials. | Front Immunol | 2023 | 38022508 | PubTator, text mining | PubMed |
| Liver X receptor alpha ensures blood-brain barrier function by suppressing SNAI2. | Cell Death Dis | 2023 | 38016947 | PubTator, text mining | PubMed |
| Comparative Analysis of Alpha and Beta HPV E6 Oncoproteins: Insights into Functional Distinctions and Divergent Mechanisms of Pathogenesis. | Viruses | 2023 | 38005929 | PubTator, text mining | PubMed |
| Notch Signaling Regulates the Function and Phenotype of Dendritic Cells in Helicobacter pylori Infection. | Microorganisms | 2023 | 38004829 | PubTator, text mining | PubMed |
Construction of an Exudative Age-Related Macular Degeneration Diagnostic and Therapeutic Molecular Network Using Multi-Layer Network Analysis, a Fuzzy Logic Model, and Deep Learning Techniques: Are Retinal and Brain Neurodegenerative Disorders Related? | Pharmaceuticals (Basel) | 2023 | 38004422 | PubTator, text mining | PubMed |
| Role of Microenvironmental Components in Head and Neck Squamous Cell Carcinoma. | J Pers Med | 2023 | 38003931 | PubTator, text mining | PubMed |
| Optimization of a Three-Dimensional Culturing Method for Assessing the Impact of Cisplatin on Notch Signaling in Head and Neck Squamous Cell Carcinoma (HNSCC). | Cancers (Basel) | 2023 | 38001580 | PubTator, text mining | PubMed |
| Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL4. | BMC Cancer | 2023 | 37993804 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54567/papers?page=15